17-AAG from BIOVISION, INC.
17-AAG from BIOVISION, INC.
| Name |
17-AAG |
| Description |
A semi-synthetic derivative of Geldanamycin (Cat. No. 1564-1,5) that displays greater stability and lower in vivo toxicity compared to Geldanamycin. Binds to Heat shock protein 90 (Hsp90) (EC?? = 7.2 µM) in a manner similar to geldanamycin. Exhibits 100-fold higher affinity for tumor-derived Hsp90 over normal cells. Also inhibits Akt activation and HER2 expression in tumor cells. |
| Size |
5 mg |
| Applications |
n/a |
| Catalog # |
1774-5 |
| Price |
$470 |
| Other Names |
Telatinib; 17-(Allylamino)-17-demethoxygeldanamycin; 17-(Allylamino)geldanamycin; Tanespimycin |
| Supplier Data Page |
17-AAG from BIOVISION, INC. |
Information on this site comes from many sources, and Linscott's
Directory disclaims responsibility for its accuracy. Pricing is supplier's
approximate list price, and actual prices may vary.
Link To Us
Bookmark Us
Supplier Login
